Literature DB >> 2732683

Characterization of a new temperature-sensitive and avirulent mutant of the rabies virus.

C Préhaud1, P Coulon, A Diallo, C Martinet-Edelist, A Flamand.   

Abstract

A temperature-sensitive (ts) mutant, tsG1, has been isolated from the CVS (Challenge Virus Standard) strain of rabies virus. The ts mutation affects the glycoprotein (G protein); it consists of an amino acid substitution (leucine to phenylalanine) at position 132. tsG1 exhibits a slightly reduced pathogenicity when administered via the intracerebral route and complete avirulence after intramuscular inoculation, associated with a very high protective power for adult mice. The ts mutation does not seem to block the transport of the G protein to the plasma membrane at the non-permissive temperature (39.6 degrees C). It abolishes the c.p.e. of the virus in cell cultures.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2732683     DOI: 10.1099/0022-1317-70-1-133

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Host switching in Lyssavirus history from the Chiroptera to the Carnivora orders.

Authors:  H Badrane; N Tordo
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  Antigenicity of rabies virus glycoprotein.

Authors:  A Benmansour; H Leblois; P Coulon; C Tuffereau; Y Gaudin; A Flamand; F Lafay
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity.

Authors:  H Badrane; C Bahloul; P Perrin; N Tordo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Nucleotide and deduced amino acid sequences of the glycoprotein gene of rabies virus vaccine strain Vnukovo-32.

Authors:  I Fodor; V I Grabko; V V Khozinski; M A Selimov
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

5.  Kinetic logic: a tool for describing the dynamics of infectious disease behavior.

Authors:  Claire Martinet-Edelist
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.